Federal · Amendment

Controlled Drugs and Substances Act schedules updated: two substances removed and chemical names standardised

Controlled Drugs and Substances Act

Recorded date: October 1, 2026
Detected: November 17, 2026. Verify commencement in the official source.

Health CareConsumer & Business

Plain-language summary · AI-assisted

The controlled substances schedules have been updated in two substantive ways. First, two entries have been deleted: methylphenobarbital (a barbiturate previously listed in Schedule IV) and 4-hydroxy-19-nortestosterone (an anabolic steroid previously listed in Schedule IV). Second, throughout all relevant schedules, Greek letter symbols (α, ß) in chemical names have been replaced with their spelled-out equivalents ('alpha', 'beta'), and one amphetamine entry (item 19(8) in Schedule I) has been clarified to explicitly name the substance as MDMA. Licence holders, importers, manufacturers, researchers, and pharmacists who work with controlled substances should review their internal documentation and compliance records to confirm they are referencing the current schedule entries, particularly regarding the two deleted substances and any systems that matched on the old Greek-character chemical name strings.

Who this affects
licensed dealers and manufacturers of controlled substances · pharmacists and dispensaries · researchers holding controlled substance licences · importers and exporters of scheduled substances · compliance and regulatory affairs teams in pharmaceutical companies

Check the official text
C-38.8 on the official source ↗

This page isn't an official version of the law and isn't legal advice. Summaries may omit details. Verify the dates and provisions that apply to you against the official source.

View this law's change history · Follow this law by RSS

Keep up with what changes.

The free weekly digest brings together published changes across our coverage. Confirm your email to subscribe.